Orofacial granulomatosis (OFG) is a term encompassing a group of immunologically mediated, recurrent or persistent, inflammatory granulomatous entities that manifest as soft-tissue enlargement of the lips and orofacial area.1 The precise cause of OFG is not fully understood and literature suggests that allergies, infections, or genetic predisposition may play a role. Studies have hypothesized that OFG is associated with, or may be a subtype of, Crohn disease.2 Management of OFG is challenging owing to its chronicity, aesthetic impact, and poor response to treatment.1,3 Herein, we report a novel surgical treatment for a rare clinical manifestation of OFG.